GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38941
Submission : 2023-10-09
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38941
Submission : 2023-10-09
Status : Active
Type : IV
FINISHED DOSAGE FORMULATIONS
Drug : BETAGAN
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Application Number : 19814
Country : US
Patented : No
Drug : BETAGAN
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Application Number : 19219
Country : US
Patented : No
PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM
Drug : BLEPHAMIDE
Dosage Form : SUSPENSION; OPHTHALMIC
Application Number : 12813
Country : US
Patented : No
Drug : ASCLERA
Dosage Form : SOLUTION; INTRAVENOUS
Application Number : 21201
Country : US
Patented : No
Drug : DECITABINE
Dosage Form : INJECTABLE; INTRAVENOUS
Application Number : 203131
Country : US
Patented : No
Drug : PREDNISOLONE SODIUM PHOSPHATE
Dosage Form : SOLUTION; ORAL
Application Number : 91396
Country : US
Patented : No
Drug : DECITABINE
Dosage Form : INJECTABLE; INTRAVENOUS
Application Number : 203475
Country : US
Patented : No
Drug : RANITIDINE HYDROCHLORIDE
Dosage Form : SYRUP; ORAL
Application Number : 76124
Country : US
Patented : No
Drug : SPRIX
Dosage Form : SPRAY, METERED; NASAL
Application Number : 22382
Country : US
Patented : No
Drug : RANITIDINE HYDROCHLORIDE
Dosage Form : SYRUP; ORAL
Application Number : 90623
Country : US
Patented : No
EXCIPIENTS BY APPLICATIONS